The Hospital Frailty Risk Score de veloped by Thomas Gilbert and colleagues 1 is an important step towards rapid, standardised, and lowcost identification of frailty in hospitalised patients (ie, admitted to hospital), and builds on the clinical utility of recently developed electronic frailty indices. 2 It reflects the increasing move towards big data, which brings more statistical power and allows the inclusion of large numbers of predictor variables.
Frailty is common among hospi talised older adults (≥65 years old) and although frailty prevalence rates vary by scale and frailty classification (ie, approaches to define frailty), 3 screening of patients with simple scales is not difficult. This simplicity contrasts with the challenge of using frailtyspecific or other riskprediction scores to identify the altogether different construct of adverse health care outcomes, particularly among older adults, because the inherent diagnostic accuracy of these scores is already low. 4, 5 Although Gilbert and colleagues acknowledge the difficulties of de riving indices from coded data, they overstate the predictive abilities of an approach that cannot capture complex patient characteristics, including dynamic functional states, caregiver characteristics, and fluctuations influenced by acute illness. 3 This limitation is reflected in the poor accuracy of this new instrument to predict mortality, readmission, and length of stay, which is similar or lower than other simpler scores. 5 This limitation is also highlighted by the theoretical illustration of the utility of the instrument in clinical practice, because further evaluation will be required for twothirds of the patients admitted to hospital (600 of 1000 intermediaterisk to highrisk admissions). Targeting such restricted and timeconsuming resources (such as comprehensive geriatric assessment) with this approach is impractical. We commend the authors for this new scoring system, but suggest that the construct they have developed is primarily useful for estimating frailty prevalence for servicelevel planning. The im plication that the Hospital Frailty Risk Score will rationalise assessment or predict adverse clinical outcomes is questionable.
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Author's reply
We thank John Soong and colleagues, Sandra M Shi and Dae H Kim, and Rónán O'Caoimh and colleagues for their careful consideration of our Article.
We note some concerns about the clinical utility of our scoring method; our approach is to position the Hospital Frailty Risk Score (HFRS) as a tool that can be implemented without the need for additional assessment or data collection, and direct high risk individuals towards frailty attuned interventions, such as the Comprehensive Geriatric Assessment (CGA). 1 We acknowledge that the HFRS can only be generated after an initial admission, so risk stratification information would not be possible at first presentation. Twothirds of people aged 75 years or older access acutecare hospitals more than once over a 2year period, and those patients who have not previously accessed hospital care are typically at low risk of hospital related adverse outcomes; thus, we view the HFRS as being especially useful to identify individuals at the highest risk of hospitalrelated harm and resource use. We accept that manual scales, such as the Clinical Frailty Scale, 2 could be used, but the HFRS has the advantage of being automated and capturing all patients, not just a selected sample.
Shi and Kim commented on the restricted discriminant ability of the HFRS; however, none of the existing frailty scales have sufficient discrimination to be able to recommend individual patient care. 3 The HFRS is particularly useful for estimating prevalence of frailty and outcomes.
We note the suggestion to analyse elective and nonelective care separately, and we agree that future iterations could focus on one or more specific areas within the hospital, and incorporate other data sources, such as physiological scores, medication, and data from primary care. During our work, we identified other clusters, which are described in table 2 of our original Comment. These clusters merit further exploration, particularly the cardiovascular and cancer clusters, in which frailty was also prevalent.
O'Caoimh and colleagues questioned whether CGA could be used at scale for frail older people in acutecare hospitals. This possibility is unproven, but strong research evidence base supports the benefits of CGA, and growing evidence shows the feasibility of implementing CGA at scale in the context of urgent care. 4, 5 We hope that the HFRS might help to target scarce resources to those patients most likely to benefit from it.
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DaisyDaisy/iStock Photo and another with 200 participants, 3 recruited within 24 h), and digital placebo trials are possible. 4 Adapting methods for personalised medicine (digital or pharmaceutical) is impor tant. In the short term, however, we must unhesitatingly adopt current standards for this new industry or unsubstantiated marketing claims will lead everyone astray.
Crucially, digital medicine must also work for the user. There seems to be little point in having an ef fective treatment that few people could use. 5 A high standard must be set because people have high expectations of digital products. In short, digital medicine needs not only to impress international clinical academic peer reviewers but make the likes of Apple jealous. Our patients deserve no less. 
Digital medicine needs to work
We applaud the editorial (July 14, p 95) 1 about the importance of data security and the clinical and cost effectiveness of digital medicine. The Digital Therapeutics Alliance is an industry consortium seeking to establish stand ards for any product claiming to be a digital therapeutic. The intention is to align digital medicine with pharmaceutical medicine in terms of evidencebased rigour, while also emphasising the centrality of the user experience.
A digital therapeutic has to work. Although the randomised controlled trial (RCT) is imperfect, it is the only acceptable starting point for a digital therapeutic. Our experience with digital cognitive behavioural therapy suggests little need for digital exceptionalism. We have pub lished eight RCTs that recruited large numbers of participants, often quickly (one with 3755 participants, 2 For more on the Digital Therapeutics Alliance see https://www.dtxalliance.org/ The politicised and crumbling Nicaraguan health system David Agren (Sept 8, p 807) 1 accurately reports on the deplorable events that have occurred in Nicaragua with regards to the right to health and other human rights since April, 2018. Nevertheless, it is important to highlight that these recent events correspond to systematic and progressive actions that have been carried out by the government for roughly a decade, since Daniel Ortega's return to power in 2007.
The politicisation of the health system goes beyond a simple perception, mentioned in the report. For more than a decade, the Sandinista government made institutional changes and took control of every branch of government, including the Supreme Court and the National Assembly. The government has established an arbitrary selection system for students pursuing a medical career in public universities and medical doctors pursuing residencies and governmentfunded scholarships for subspecialisations abroad (mostly in Mexico). Administrative positions, such as heads of SILAIS (integrated local health systems), across the country are exclusively reserved for militants of the ruling party, who are expected to act, before anything else, as political operators. At the community level, brigadistas (community health workers) not only carry out preventive and health promotion activities but also political activism and proselytism in their assigned territories. Many of them are members of the Gabinetes de la familia, la comunidad, y la vida (Councils of Family, Community, and Life), the political arms of the Sandinista party (FSLN) in urban neighbourhoods and rural communities. 2 Besides, rampant lack of transparency and social accountability have become characteristics of the health system
